Medicare Enrolled
Dr. Shachar Peles, M.D.
Hematology · Palm Springs, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Peles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peles?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Peles
Dr. Shachar Peles is a hematology specialist in Palm Springs, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Peles performed 175,748 Medicare services across 4,127 unique beneficiaries.
Between the years covered by Open Payments, Dr. Peles received a total of $212,694 from 95 pharmaceutical and/or device companies across 1234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Peles is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 28% volume in FL
$212,694 industry payments
Medicare Practice Summary
Medicare Utilization ↗175,748
Medicare services
Top 28% in FL for hematology
4,127
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,250 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
27,360 | $38 | $110 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
25,200 | $0 | $2 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
23,460 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 19,000 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 17,940 | $1 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
9,500 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 9,180 | $19 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
8,581 | $6 | $23 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
6,806 | $36 | $108 |
| Iron infusion (Monoferric) | 6,100 | $17 | $57 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
3,091 | $8 | $29 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,071 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,803 | $8 | $9 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,260 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,710 | $1 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,369 | $98 | $339 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,204 | $68 | $239 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
970 | $11 | $69 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
768 | $2 | $7 |
| Anti-nausea injection (ondansetron/Zofran) | 584 | $0 | $9 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
514 | $1 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
491 | $104 | $378 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
452 | $12 | $61 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
391 | $50 | $189 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
385 | $7 | $69 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
322 | $23 | $84 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
247 | $57 | $206 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
186 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
179 | $22 | $79 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
154 | $16 | $56 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
107 | $10 | $42 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
94 | $45 | $170 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
92 | $2 | $7 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
90 | $25 | $156 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
90 | $123 | $453 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $139 | $562 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
72 | $52 | $178 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
71 | $137 | $637 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
69 | $16 | $56 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
69 | $139 | $474 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
66 | $1 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
62 | $2 | $8 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
61 | $5 | $20 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
53 | $3 | $11 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $65 | $197 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
41 | $26 | $89 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
33 | $29 | $156 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
31 | $19 | $59 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $131 | $556 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
24 | $126 | $467 |
| New patient office visit, complex (60-74 min) | 24 | $169 | $585 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 24 | $401 | $680 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
23 | $1,164 | $3,706 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
21 | $49 | $344 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
20 | $185 | $550 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
18 | $97 | $285 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
14 | $73 | $277 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $107 | $377 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
12 | $103 | $430 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
11 | $67 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.7% high complexity
73.1% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$212,694
Total received (2018-2024)
Avg $30,385/year across 7 years
Top 1% in FL for hematology
95
Companies
1,234
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$166,931 (78.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$28,480 (13.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,283 (8.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,774
2023
$13,004
2022
$11,762
2021
$8,670
2020
$13,780
2019
$54,323
2018
$92,381
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$69,745
Celgene Corporation
$28,941
Karyopharm Therapeutics Inc.
$26,859
Janssen Biotech, Inc.
$22,460
Janssen Scientific Affairs, LLC
$18,301
Seattle Genetics, Inc.
$13,542
GlaxoSmithKline, LLC.
$6,063
Verastem, Inc.
$3,750
AbbVie, Inc.
$3,221
PFIZER INC.
$1,421
Bayer HealthCare Pharmaceuticals Inc.
$1,388
Novartis Pharmaceuticals Corporation
$1,254
Epizyme, Inc.,
$1,250
AstraZeneca Pharmaceuticals LP
$1,075
Adaptive Biotechnologies Corporation
$986
E.R. Squibb & Sons, L.L.C.
$841
GENZYME CORPORATION
$780
Amgen Inc.
$736
Merck Sharp & Dohme LLC
$713
Incyte Corporation
$712
Genentech USA, Inc.
$542
Seagen Inc.
$530
Daiichi Sankyo Inc.
$521
BeiGene USA, Inc.
$455
Merck Sharp & Dohme Corporation
$454
Boehringer Ingelheim Pharmaceuticals, Inc.
$336
Astellas Pharma US Inc
$322
Lilly USA, LLC
$312
Blueprint Medicines Corporation
$312
Alexion Pharmaceuticals, Inc.
$294
ABBVIE INC.
$289
Eisai Inc.
$279
Ipsen Biopharmaceuticals, Inc
$218
Pharmacyclics LLC, An AbbVie Company
$212
PUMA BIOTECHNOLOGY, INC.
$199
EMD Serono, Inc.
$190
ARRAY BIOPHARMA INC
$187
Dendreon Pharmaceuticals LLC
$161
Regeneron Healthcare Solutions, Inc.
$159
Deciphera Pharmaceuticals Inc.
$149
TerSera Therapeutics LLC
$124
Puma Biotechnology, Inc.
$122
Bayer Healthcare Pharmaceuticals Inc.
$115
AVEO Pharmaceuticals, Inc.
$104
Spectrum Pharmaceuticals Inc.
$104
Janssen Products, LP
$100
Kite Pharma, Inc.
$89
Mirati Therapeutics, Inc.
$81
Taiho Oncology, Inc.
$73
Dova Pharmaceuticals
$72
AbbVie Inc.
$67
Sirtex Medical Inc
$65
Rigel Pharmaceuticals, Inc.
$64
Heron Therapeutics, Inc.
$63
Shire North American Group Inc
$60
Pharmacyclics LLC, an AbbVie Company
$59
TESARO, Inc.
$58
Gilead Sciences, Inc.
$57
Agios Pharmaceuticals, Inc.
$56
Exelixis Inc.
$52
Kyowa Kirin, Inc.
$51
ADC Therapeutics America, Inc.
$46
Lexicon Pharmaceuticals, Inc.
$45
Legend Biotech USA Inc.
$45
Clovis Oncology, Inc.
$44
MEDIVATION FIELD SOLUTIONS LLC
$43
TG THERAPEUTICS, INC.
$42
Aurobindo Pharma USA, Inc.
$40
Aveo Pharmaceuticals, Inc.
$40
JAZZ PHARMACEUTICALS INC.
$40
Emmaus Medical, Inc.
$38
Alnylam Pharmaceuticals Inc.
$38
G1 Therapeutics, Inc.
$35
MorphoSys, US Inc.
$29
Pharmacosmos Therapeutics Inc.
$29
Blue Earth Diagnostics Limited
$28
EISAI INC.
$27
SERVIER PHARMACEUTICALS LLC
$25
Myriad Genetic Laboratories, Inc.
$22
RECORDATI_RARE_DISEASES_INC.
$20
ImmunoGen, Inc.
$19
Coherus Biosciences Inc.
$19
SANOFI-AVENTIS U.S. LLC
$18
Stemline Therapeutics Inc.
$17
Partner Therapeutics, Inc.
$17
Advanced Accelerator Applications
$17
Sobi, Inc
$16
TAIHO ONCOLOGY, INC.
$15
SOBI, INC
$14
Acrotech Biopharma LLC
$13
Teva Pharmaceuticals USA, Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$12
Foundation Medicine, Inc.
$12
Iovance Biotherapeutics, Inc.
$11
Janssen Pharmaceuticals, Inc
$7
Top 3 companies account for 59.0% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Amtagvi · Avastin · Axumin · BAVENCIO · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cinvanti · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EVENITY · Elahere · Endari · Enhertu · FOTIVDA · FOUNDATIONONE · Folotyn · GATTEX · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · HYQVIA · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · IMLYGIC · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tazverik · Tecentriq · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology in FL.
Equivalent to $121 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
11
Per 100K population
0.7
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Peles is a mixed practice specialist, with above-average Medicare volume (top 28% in FL), with speaking/promotional industry engagement in the top 1% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Peles experienced with daratumumab injection (darzalex)?
Based on Medicare claims data, Dr. Peles performed 27,360 daratumumab injection (darzalex) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Peles receive payments from pharmaceutical companies?
Yes. Dr. Peles received a total of $212,694 from 95 companies across 1,234 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peles's costs compare to other hematologists in Palm Springs?
Dr. Peles's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Palm Springs
Browse hematologists in Palm Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology